Neurobiology of OB protein (leptin) introduction

Frontiers of Hormone Research

Volumn 26, Issue , 1999, Pages 1-11

  Arthur Campfield, L ^a  

^a Hoffman La Roche Department of Metabolic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; LEPTIN; LEPTIN RECEPTOR; NEUROPEPTIDE;

ANIMAL; BRAIN; HUMAN; OBESITY; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; CARRIER PROTEINS; HUMANS; LEPTIN; NEUROPEPTIDES; OBESITY; RECEPTORS, CELL SURFACE;

EID: 54249120131     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (31)

1. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Baur TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
2. Campfield LA, Smith FJ: Overview: Neurobiology of OB protein (leptin). Proc Nutr Soc 1998;57:429-440.
3. Thomas PR (ed): Weighing the Options: Criteria for Evaluating Weight-Management Programs. Food and Nutrition Board, Institute of Medicine, Washington, National Academy Press, 1995.
4. Bjorntorp P, Brodoff BN (ed): Obesity. Philadelphia, Lippincott, 1992.
5. Campfield LA: Treatment options and the maintenance of weight loss; in Allison DB, Pi-Sunyer FX (eds): Obesity Treatment: Establishing Goals, Improving Outcomes, and Reviewing the Research Agenda. New York, Plenum Press, 1995, pp 93-95.
6. Leibe RL, Rosenbaum M, Hirsch J: Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;232:621-628.
7. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang P-L, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 1996;348:159-161.
8. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 1996;2:589-593.
9. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
10. Golden PL, Maccagnan TJ, Pardridge WM: Human blood-brain barrier leptin receptor: Binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997:99:14-18.
11. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards JG, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor (OB-R). Cell 1995;83:1263-1271.
12. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P: Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996;387:113-116.
13. Schwartz MW Seeley RJ, Campfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101-1106.
14. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Diby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins B, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
15. Strobel A, Issad T, Camoin L, Ozata M, Strosberg D: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genetics 1998;18:213-215.
16. Clement K, Valisse C, Lahlou N, Cabrol S, Peeloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacourte M, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
17. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
18. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKeller W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
19. Thiele TE, van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ: Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am J Physiol 1997;272:R726-R730.
20. Yokosuka M, Xu B, Pu S, Karla SP: The magnocellular part of the paraventricular hypothalamic nucleus (PVN): A selective site for inhibition of NPY-induced food intake by leptin. Soc Neurosci Abstr 1997;23:852.
21. Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakrzewska K, Jeanrenaud B: Neuropeptide Y and leptin in lean and genetically obese fa/fa rats. Horm Metab Res 1996;28:642-648.
22. Ezzell C: Fat times for obesity research: Tons of new information, but how does it all fit together. J NIH Res 1995;7:39-45.
23. Smith FJ, Campfield LA, Moschera JA, Bailon P, Burn P: Feeding inhibition by neuropeptide Y. Nature 1996;382:307.
24. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y Nature 1996;381:415-418.
25. Huang Q, Rivest R, Richard D: Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 1998;139:1524-1532.
26. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
27. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Melanocortinergic inhibition of feeding behavior and disruption with an agouti-mimetic. Nature 1997;385:165-168.
28. Hakansson M-L, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-572.
29. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B: Glucocorticoids as counterregulatory hormones of leptin: Toward an understanding of leptin resistance. Diabetes 1997;46:717-719.
30. Glaum SR, Hara M, Bindokas V, Lee C, Polonsky K, Bell G, Miller R: Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 1996;50:230-235.
31. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford MLJ: Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997;390:521-525.